Lexaria Bioscience (LEXX) Other Gross PP&E Adjustments (2017 - 2025)
Lexaria Bioscience's Other Gross PP&E Adjustments history spans 9 years, with the latest figure at $697487.0 for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 644.81% year-over-year to $697487.0; the TTM value through Nov 2025 reached $697487.0, up 644.81%, while the annual FY2025 figure was $665510.0, 11.95% up from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was $697487.0 at Lexaria Bioscience, up from $665510.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $697487.0 in Q4 2025 and bottomed at -$737903.0 in Q4 2022.
- The 5-year median for Other Gross PP&E Adjustments is -$118665.5 (2021), against an average of -$19112.9.
- The largest annual shift saw Other Gross PP&E Adjustments tumbled 909.18% in 2023 before it surged 644.81% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$81656.0 in 2021, then tumbled by 803.67% to -$737903.0 in 2022, then surged by 78.78% to -$156565.0 in 2023, then rose by 18.23% to -$128025.0 in 2024, then soared by 644.81% to $697487.0 in 2025.
- Per Business Quant, the three most recent readings for LEXX's Other Gross PP&E Adjustments are $697487.0 (Q4 2025), $665510.0 (Q3 2025), and $658311.0 (Q2 2025).